School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Drugs Aging. 2023 Feb;40(2):117-134. doi: 10.1007/s40266-022-01001-5. Epub 2023 Jan 24.
Drug-drug interactions (DDIs) can lead to medication-related harm, and the older population is at greatest risk. We conducted a systematic review and meta-analysis to estimate DDI prevalence and identify common DDIs in older community-dwelling adults.
PubMed and EMBASE were searched for observational studies published between 01/01/2010 and 10/05/2021 reporting DDI prevalence in community-dwelling individuals aged ≥ 65 years. Nursing home and inpatient hospital studies were excluded. Study quality was assessed using the Joanna Briggs Institute critical appraisal tool. Meta-analysis was performed using a random-effects model with logit transformation. Heterogeneity was evaluated using Cochran's Q and I. DDI prevalence and 95% confidence intervals (CIs) are presented. All analyses were performed in R (version 4.1.2).
There were 5144 unique articles identified. Thirty-three studies involving 17,011,291 community-dwelling individuals aged ≥ 65 years met inclusion criteria. Thirty-one studies reported DDI prevalence at the study-participant level, estimates ranged from 0.8% to 90.6%. The pooled DDI prevalence was 28.8% (95% CI 19.3-40.7), with significant heterogeneity (p < 0.10; I = 100%; tau = 2.13) largely explained by the different DDI identification methods. Therefore, 26 studies were qualitatively synthesised and seven studies were eligible for separate meta-analyses. In a meta-analysis of three studies (N = 1122) using Micromedex, pooled DDI prevalence was 57.8% (95% CI 52.2-63.2; I = 69.6%, p < 0.01). In a meta-analysis of two studies (N = 809,113) using Lexi-Interact, pooled DDI prevalence was 30.3% (95% CI 30.2-30.4; I = 6.8%). In a meta-analysis of two studies (N = 947) using the 2015 American Geriatrics Society Beers criteria, pooled DDI prevalence was 16.6% (95% CI 5.6-40.2; I = 97.5%, p < 0.01). Common DDIs frequently involved cardiovascular drugs, including ACE inhibitor-potassium-sparing diuretic; amiodarone-digoxin; and amiodarone-warfarin.
DDIs are prevalent among older community-dwelling individuals; however, the methodology used to estimate these events varies considerably. A standardised methodology is needed to allow meaningful measurement and comparison of DDI prevalence.
药物-药物相互作用(DDI)可导致药物相关伤害,而老年人面临的风险最大。我们进行了一项系统评价和荟萃分析,以估计老年人社区居住者中 DDI 的发生率,并确定常见的 DDI。
检索 2010 年 1 月 1 日至 2021 年 10 月 5 日期间发表的观察性研究,以报告年龄≥65 岁的社区居住者中 DDI 的发生率。排除疗养院和住院患者的研究。使用 Joanna Briggs 研究所的批判性评估工具评估研究质量。使用随机效应模型和对数变换进行荟萃分析。使用 Cochran's Q 和 I 评估异质性。呈现 DDI 的发生率和 95%置信区间(CI)。所有分析均在 R(版本 4.1.2)中进行。
共确定了 5144 篇独特的文章。33 项涉及≥65 岁的 17011291 名社区居住者的研究符合纳入标准。31 项研究报告了研究参与者水平的 DDI 发生率,估计值范围为 0.8%至 90.6%。总体 DDI 发生率为 28.8%(95%CI 19.3-40.7),差异显著(p<0.10;I=100%;tau=2.13),主要由不同的 DDI 识别方法解释。因此,26 项研究进行了定性综合分析,7 项研究适合单独进行荟萃分析。在使用 Micromedex 的三项研究(N=1122)的荟萃分析中,DDI 发生率为 57.8%(95%CI 52.2-63.2;I=69.6%,p<0.01)。在使用 Lexi-Interact 的两项研究(N=809113)的荟萃分析中,DDI 发生率为 30.3%(95%CI 30.2-30.4;I=6.8%)。在使用 2015 年美国老年医学学会 Beers 标准的两项研究(N=947)的荟萃分析中,DDI 发生率为 16.6%(95%CI 5.6-40.2;I=97.5%,p<0.01)。常见的 DDI 常涉及心血管药物,包括 ACE 抑制剂-保钾利尿剂;胺碘酮-地高辛;胺碘酮-华法林。
DDI 在老年人社区居住者中很常见;然而,用于估计这些事件的方法差异很大。需要一种标准化的方法来允许对 DDI 发生率进行有意义的测量和比较。